Titomic Limited Overview
Titomic is a small-cap advanced-manufacturing company built around a proprietary solid-state metal deposition process, Titomic Kinetic Fusion™ (TKF™). TKF is a form of cold spray, originally co-developed with Australia's CSIRO. It accelerates metal powder to supersonic velocity so the particles bond without melting, which allows Titomic to manufacture, coat and repair metal components. Over 2024–2026 the company moved from an Australian equipment vendor with a Dutch low/medium-pressure systems arm to a US-headquartered "production, repair and sustainment" business inside the US and allied defence industrial base. Its centre of gravity is now a 59,000 sq ft Huntsville, Alabama plant, which is AS9100-certified. Revenue remains small (about A$10M on a trailing basis) and losses are large (about A$19M in H1 2026 alone). The investment case therefore rests on converting a defence-prime, US Navy/USAF, aerospace MRO, energy and semiconductor pipeline into recurring production revenue before balance-sheet constraints force further heavy dilution.
Company self-description (latest filings)
Titomic's standard description in its 2026 ASX releases is broadly as follows. It calls itself an advanced manufacturing company with global operations. It specialises in large integrated solutions for industrial-scale metal additive manufacturing, coating and repair using its patented kinetic fusion cold spray technology. It provides OEM production and R&D services to aerospace, defence, shipbuilding, oil and gas, mining and automotive customers, with global sales and support run from the Huntsville headquarters and local presence in Australia and Europe (Q2 2026 Quarterly Activities Report, 31 Jul 2026). In the TP2025 annual report release (27 Feb 2026), management described the company as a "production-scale cold spray manufacturing company operating inside the U.S. and allied defense industrial base." Later releases (Oct 2026) add semiconductors to the end-market list.
Independent characterisation
Titomic is best understood as a hybrid with three activities:
-
An industrial capital-equipment OEM. It sells cold spray systems across low-, medium- and high-pressure classes, which customers install for their own repair, coating or additive production. This was historically the dominant revenue line, anchored by the Dutch Dycomet heritage (acquired 2021).
-
A contract manufacturer and repair house. It produces qualified parts, near-net-shape builds and repairs in Huntsville and Heerenveen. Defence primes, US Navy and USAF depots, oil and gas operators, aerospace MRO shops and a semiconductor customer use it for low-rate and full-rate production.
-
An aftermarket and recurring-revenue platform. This covers powder supply, consumables, spare parts, training, service, leasing and "repair-as-a-service." Management has flagged this as the strategic pivot toward higher-margin recurring revenue (FY2025 Annual Report release).
Revenue model mix
| Revenue stream | Nature | Current weight (qualitative) | Evidence |
|---|---|---|---|
| System sales (TKF™ / Dycomet-heritage machines) | One-off capital equipment | Historically the largest; still material (e.g., US$5.0M USAF system, Sep 2026; Lufthansa Technik >A$1.2M, May 2026; Compass Systems >US$400k for two TKF™623 systems, Oct 2026) | ASX releases 2026 |
| Contract production / parts | Program-based; LRIP moving to full-rate | Emerging; semiconductor full-rate contract worth about A$1.5M in 2027 and up to A$3.2M in 2028 | Semiconductor release, 7–8 Oct 2026 |
| Repair, coating and restoration services | Job-based; potentially recurring | Emerging (oil and gas emergency repair, EOS refurbishment, US Navy evaluations) | Q2 2026 4C report |
| Qualification / R&D / testing services | Contracted studies | Material in count, small in value (Bechtel Plant Machinery US$250k; Royal Netherlands Army €150k; US$534k across four US orders) | Oct 2026 releases |
| Powder, consumables, spares, training, leasing | Recurring aftermarket | Stated strategic priority; not separately quantified | FY2025 Annual Report release |
| IP licensing | Royalty / licence | Not a disclosed revenue line | — |
Titomic does not publicly disclose an exact split between product, service, subscription and licensing revenue in the sources reviewed. Qualitatively:
Value-chain position
Titomic sits in the midstream of the metal-component value chain, between metal powder suppliers upstream and OEMs, defence primes, depots and MRO operators downstream. Through its own production cells it also increasingly acts as a Tier-2/Tier-3 supplier to defence primes. Unlike laser powder-bed fusion vendors, its process is solid-state, which avoids melt-related distortion and phase changes. It suits large parts, dissimilar-metal combinations, refractory metals, and field-deployable or shipboard repair.
Customer types and end-markets
Defence (US and allied): US defence primes (unnamed prime's Early Manufacturing Development program), US Navy (Fleet Readiness Center Southwest via Compass Systems; Pacific Battle Damage Exercise 2026; submarine industrial base via Bechtel Plant Machinery), US Air Force (Tinker AFB depot system), Royal Netherlands Army, and a US military research organisation (CRADA).
Aerospace and MRO: Lufthansa Technik (Hamburg), NASA (Space Act Agreement, Feb 2026).
Energy / oil and gas: a major oil and gas operator (repair qualification and emergency repair), Saudi Arabia and Norway contracts (about A$550k, Sep 2026), DNV qualification for in-field aluminium corrosion coatings, and a global energy technology company (TKF™623 order).
Semiconductor: an undisclosed customer of Titomic Europe on full-rate production.
Rail / transportation: Deutsche Bahn (Jan 2026).
Industrial / AM ecosystem: EOS (component refurbishment), plus universities and research institutes as legacy Dycomet customers.
Strategy
Stated strategy (themes from the FY2025 annual report, TP2025 annual report, Investor Day 2026 and quarterly reports)
-
"American-headquartered" defence-industrial-base positioning. Become, in the CEO's Q2 2026 framing, the premier advanced manufacturing company supporting the US and allied defence industrial base.
-
Pivot from machines to services and recurring revenue. Move to a high-margin service and leasing model underpinned by powder supply, training and repair-as-a-service (FY2025 Annual Report release).
-
Production-pathway conversion. Move programs through qualification, then low-rate initial production (LRIP), then full-rate production. The TP2025 report emphasised the transition from technical validation toward production integration.
-
Vertical integration. Build an end-to-end manufacturing enterprise (machining, metrology, pre/post-processing) rather than remain an equipment vendor (Q2 2026 report).
-
Diversified end-markets toward 2030: Defence and Aerospace; Oil and Gas / Maritime; MRO / Aviation; Transportation; Systems, Powder and Leasing; with semiconductors added in 2025–2026.
-
Corporate re-domiciliation to the US, with a possible future US exchange listing "at an appropriate time" (12 Mar 2026).
Strategic initiatives in the last 24 months
| Initiative | Date | Details / targets | Status |
|---|---|---|---|
| Huntsville global HQ and manufacturing hub | Opened Jun 2025 | 59,000 sq ft; AS9100 (Apr 2026); manufacturing build-out "substantially complete" (Jul 2026) | Complete; second hall in planning |
| Change of fiscal year-end to 31 Dec | Announced Aug 2025 | Align with US and Netherlands subsidiaries | Complete |
| US redomiciliation via scheme of arrangement | Announced 12 Mar 2026; SID 12 May 2026 | Titomic, Inc. (Delaware) to become parent; ASX trading via CDIs; independent expert RSM Corporate Australia; advisers Norton Rose Fulbright Australia and Fluet & Associates | Pending; implementation now expected by 30 Nov 2026 (revised 24 Sep 2026) |
| Non-dilutive US financing | 2025–2026 | About US$24M OSC loan flagged Aug 2025. In 2026 the company targeted US$25M across EXIM (Make More in America) and OSC; the same 4C also says US$25M from each, which is internally inconsistent. JP Morgan engaged as adviser. EXIM direct loan of about US$10M progressing (Sep 2026). | In progress; EXIM feedback was expected in Q3 2026 and OSC in Q4 2026 |
| Other grants and funding | 2,025 | €800k Dutch Ministry of Economic Affairs (3D PK) grant secured. In progress as at Aug 2025: US DPA Title III, SBIR/STTR, and Australian National Reconstruction Fund (A$5M). | Mixed |
| Equity raises | Oct 2024; Jul 2025; Sep 2026 | A$30M; A$50M; A$16.5M (A$6M facility and equipment, A$6M working capital and reserves, A$2.3M technology/automation/digital, balance for hires) | Completed |
| TKF™ Tactical (shipboard) | May–Jul 2026 | Redesign from Navy feedback at PBDE 2026 | Demonstrated |
| Strategic advisory groups (US and Europe) | 2025–2026 | Defence market access | Established |
| Cost restructure | 15 Oct 2026 | About A$3.0M annualised savings; A$0.6M one-off cost; complete by end Oct 2026 | Under way |
| ESG / sustainability commitments | — | No formal emissions targets or ESG program disclosed in reviewed sources | — |
Medium-term targets and guidance
| Target | Source / date | Status of credibility |
|---|---|---|
| US$750M annual revenue by 2030 | FY2025 Annual Report release, 28 Aug 2025 | Aspirational. Requires about 100-fold growth from a trailing revenue of about A$10M (about US$6.5M). |
| About A$50M (or US$50M) revenue target discussed at Investor Day 2026, alongside recurring defence contracts | Investor Day summary, Mar 2026 (Quartr) | — |
| 13 "conversion programs" with illustrative 2026–2030 revenue potential of US$250–430M (explicitly not forecasts or contracted revenue) | A$16.5M placement materials, Sep 2026 | Illustrative only |
| Revenue growth for the remainder of 2026, from defence, energy, maritime sustainment and machine sales | Appendix 4D H1 2026 | Near-term guidance (qualitative) |
| Cash flow and EBITDA break-even during 2027 | Q2 2026 4C; placement; restructure | Key monitorable |
| Semiconductor contract revenue of about A$1.5M in 2027 and up to about A$3.2M in 2028 | 8 Oct 2026 | Contract-specific |
Products & Services
Titomic does not publish a public price list, so pricing is "not publicly disclosed" unless inferred from disclosed contract values (shown as indicative).
Systems (equipment)
| Product | Description / capabilities | Target customer | Latest version / year | Pricing (disclosed or implied) |
|---|---|---|---|---|
| TKF™ 3250 | Flagship large-format high-pressure TKF™ production system installed at Huntsville; used for large structural builds, refractory and high-strength alloys | Titomic's own production; defence primes; large depots | Installed at Huntsville during its first operating year (Jun 2025–Jun 2026) | — |
| TKF™ 1000 | High-pressure production/R&D system installed at Huntsville | Production; R&D partners | Installed 2025–2026 | — |
| TKF™ 623 | Medium-pressure cold spray system; DNV-qualified (with low-pressure systems) for in-field aluminium corrosion coatings | Navy depots (FRC Southwest), energy companies, MRO | Current; orders Sep–Oct 2026 | Implied about US$200k per system (two systems for more than US$400k, Compass Systems PO, 14 Oct 2026) |
| TKF™ 523 | Low-pressure portable cold spray system for coatings and repair | MRO, oil and gas field service, maritime | Current | — |
| TKF™ Tactical | TKF™ 523 redesigned into a pelican-case, ship-hatch-compatible unit running on shipboard air and power, developed from US Navy feedback at PBDE 2026; demonstrated 14–15 Jul 2026 | US Navy shipboard / expeditionary repair | 2026 (prototype / demonstration stage) | — |
| Turnkey low-pressure systems (Europe) | Dycomet-heritage turnkey low-pressure systems with software, lab support and servicing | Aerospace MRO (Lufthansa Technik Hamburg), automotive, academia | Ongoing | Lufthansa Technik contract more than A$1.2M (US$830k) for additional capability including a turnkey low-pressure system (May 2026) |
| High-pressure systems for depots | Cold spray manufacturing system for a major USAF maintenance depot | US Air Force | Contract 14 Sep 2026 | US$5.0M contract (system configuration not specified) |
| Legacy very-large TKF high-pressure cell (Melbourne) | Large-scale additive system built around 2017 to showcase titanium AM | Historic demonstrator | 2017–2018 | Not applicable |
Manufacturing and production services
| Offering | Description | Target customer | Status / flagship example |
|---|---|---|---|
| Contract production (LRIP → full-rate) | Qualified production of components using TKF™ | Semiconductor equipment supply chain; defence primes | Full-rate semiconductor contract (Titomic Europe, Oct 2026) following a 2025 LRIP run |
| Early Manufacturing Development (EMD) builds | Prototype/production articles with proprietary multi-material combinations | Leading US defence prime (unnamed) | Article delivered Jun 2026 and used in a test (Q2 2026 report) |
| Refractory-metal manufacturing | Builds using strategic refractory metal inventory (more than A$0.7M purchased Q2 2026) | Defence munitions/propulsion programs | Ongoing |
| Qualification and materials testing | Deposition and mechanical testing (titanium alloy, high-strength steel, aluminium alloy, wear-resistant coatings) | US defence/research customers | Program due for completion by end Nov 2026 (Sep 2026 orders) |
Repair, coating and sustainment services
| Offering | Description | Target customer | Flagship example |
|---|---|---|---|
| Rapid component repair | Restoration of worn or damaged parts in days or weeks | Oil and gas, defence, AM OEMs | One-week emergency repair preventing an oil and gas production shutdown; EOS refurbishment in under a week (Q2 2026) |
| Corrosion-protection coatings | In-field thermal-spray-aluminium alternative | Oil and gas / maritime | DNV Statement of Qualification (Apr 2026) |
| Battle damage repair | Frontline repair prototype development | Royal Netherlands Army | €150k prototype contract (Oct 2026) |
| Submarine industrial-base repair materials | Evaluation of advanced repair materials/processes | Bechtel Plant Machinery (US Navy) | Initial US$250k contract (Oct 2026) |
| Repair-as-a-service | Bundled service model | Industrial customers | Stated strategic model (FY2025 Annual Report release) |
Aftermarket and recurring
| Offering | Description | Status |
|---|---|---|
| Powder supply | Metal powders for installed TKF™ base | Stated recurring pillar; revenue not disclosed |
| Spare parts and consumables | Nozzles, wear parts, service kits | Ongoing (Dycomet heritage) |
| Training and certification | Operator and process training | Ongoing |
| Leasing | Systems leasing ("Systems, Powder & Leasing" named among 2030 revenue pillars) | Stated pillar; size not disclosed |
| Software / AR tools | Augmented-reality support for cold spray systems (announced around Q1 FY2025) | Feature, not separately monetised |
Financial Narrative
Income statement
Sources: S&P Global Market Intelligence via StockAnalysis.com (income statement and cash flow, accessed Oct 2026). EBITDA is operating income plus D&A. Pre-tax income is derived from the S&P pretax margin. Company-reported headline revenue: FY2024 A$5.9M; FY2025 A$8.1M (+37%) (FY2025 Annual Report release, 28 Aug 2025). The difference from the S&P figures reflects inclusion of other income (e.g., grants and R&D tax incentives) in the S&P "total revenue" line. Net loss FY2025 of A$19.89M is consistent across sources. For FY2023, one aggregator reports a net loss of A$15.33M against S&P's A$15.71M; discrepancy flagged.
Margins (%)
Revenue CAGR FY2022–FY2025 (S&P basis): about 21.0% per year (A$5.32M to A$9.43M). On company headline revenue, FY2024–FY2025 growth was 37%.
Post-FY2025 periods (company-reported)
Sources: TP2025 Annual Report summary (27 Feb 2026, via Quartr); Appendix 4D H1 2026 (31 Aug 2026, via Quartr summary); Appendix 4C Q2 2026 (31 Jul 2026). Data conflict: one aggregator (StockAnalysis) shows H1 2026 revenue growth of +23.3%. The company's Appendix 4D figure of -11.1% is used here as the primary source.
Commentary — income statement. Titomic's revenue base has roughly doubled since FY2022, but the cost base has grown faster. Three inflections stand out:
-
FY2024 was the "efficiency" year. Gross margin reached 35.9% and the operating loss narrowed to A$11.0M as Dycomet-heritage system sales scaled in Europe and overhead was cut after the FY2023 crisis.
-
FY2025 marked the US build-out. Gross margin collapsed to 12.0%, and S&P data indicate negative gross profit in the trailing period to Dec 2025. Under-absorbed Huntsville capacity, inter-company equipment transfers and start-up production costs drove this. Operating losses almost doubled to A$19.8M, with stock-based compensation rising to A$6.0M as management was recruited with equity.
-
TP2025 and H1 2026 confirm a burn rate of about A$18–19M of net loss per half. That is roughly four times half-yearly revenue, as Titomic absorbs US manufacturing, certification, qualification and redomiciliation costs ahead of revenue.
Management's explicit response is the Oct 2026 restructure (about A$3.0M of annualised savings) and the 2027 cash flow and EBITDA break-even target.
Balance sheet
Source: S&P Global Market Intelligence via StockAnalysis.com (balance sheet), from Titomic annual reports FY2022–FY2025 and TP2025. PP&E at 31 Dec 2025 included land A$10.79M, buildings A$2.24M, machinery A$11.13M and construction in progress A$9.87M.
Latest (30 Jun 2026) disclosed balance-sheet items. Cash A$14.26M. Loan facility from First National Bank of Pulaski of A$5.82M total (A$4.95M drawn), at 6.12% interest, secured by a US$4.0M (A$5.8M) term deposit earning about 3.3%. The facility is non-amortising and not due while it remains secured; the company plans to repay or refinance it on reaching break-even (Appendix 4C Q2 2026). The Appendix 4C wording leaves it unclear whether the pledged term deposit sits within the reported A$14.26M cash balance or alongside it; this is not resolved in the reviewed filing.
Commentary — balance sheet. The balance sheet was transformed by about A$80M of equity raised across Oct 2024 (A$30M) and Jul 2025 (A$50M). Equity went from negative at June 2023 to A$47.8M at December 2025, and assets shifted into US land, buildings and production equipment. Intangibles are nil: Titomic does not carry capitalised IP on its balance sheet, and the Dycomet goodwill was written off historically.
The common-stock and retained-earnings lines moved between FY2024 (A$75.2M / -A$84.6M) and FY2025 (A$23.1M / -A$23.0M). This is consistent with a capital reduction applied against accumulated losses, an accounting reclassification with no cash effect.
From December 2025 to June 2026 cash fell by A$21.5M in six months. The September 2026 A$16.5M placement (about A$15.6M net, analyst estimate) restored pro-forma liquidity to roughly A$30M before Q3 2026 burn. That is still only about four to five quarters of runway at the H1 2026 operating plus investing burn rate, absent the targeted non-dilutive debt.
Cash flow
Sources: FY2022–FY2025 from S&P via StockAnalysis.com. TP2025 operating cash flow and capex are derived (S&P TTM to 30 Jun 2026 less Appendix 4C H1 2026 year-to-date) and should be treated as indicative. TP2025 equity is the company-announced A$50M raise; the S&P aggregation shows a higher figure that could not be reconciled and is flagged.
H1 2026 cash flow (Appendix 4C, AUD M): operating -14.28; investing -6.63; financing +0.27; FX -0.87. Q2 2026 alone: operating -8.26 (vs -7.1 in Q1); investing -2.30 (vs -4.4 in Q1); customer receipts 1.48, which was lower than anticipated because A$0.5M of payments slipped into July and some orders moved into Q3.
Commentary — cash flow. Titomic has never generated positive operating cash flow. The step-change in burn from FY2025 onward is structural rather than cyclical: US headcount, a second production hall, certification and redomiciliation costs. Investing outflows are now tapering as the Huntsville build-out is "substantially complete" (Q2 2026 4C). Management's stated mitigants are customer-receipt growth in H2 2026, the A$3.0M restructure, and about US$25M of targeted non-dilutive funding from US EXIM and the Office of Strategic Capital (OSC). On the EXIM component, a direct loan of about US$10M was reported in Sep 2026 as progressing through EXIM's internal underwriting.
Ratios
Computable ratios (fiscal year-end basis)
Notes: TP2025 ROA and asset turnover are six-month, non-annualised figures. FY2023 debt-to-equity is negative because shareholders' equity was negative (A$-0.71M).
Ratios not meaningful (n/m) given persistent losses
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Australia segment revenue (AUD Mn) | 4.38 | 3.01 | 3.85 | 4.96 |
USA segment revenue (AUD Mn) | 0.03 | 0.37 | 0.54 | 3.92 |
Europe segment revenue (AUD Mn) | 1.45 | 2.70 | 5.20 | 7.27 |
Intersegment eliminations (AUD Mn) | -0.54 | -1.59 | -1.89 | -6.72 |
Total revenue S&P basis (AUD Mn) | 5.32 | 4.49 | 7.70 | 9.43 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%)
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Australia YoY growth (%) | -31.3 | 27.9 | 28.8 |
USA YoY growth (%) | 1,133.3 | 45.9 | 625.9 |
Europe YoY growth (%) | 86.2 | 92.6 | 39.8 |
Revenue by Segment (%)
| Segment | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Australia share of gross segment revenue (%) | 74.6 | 49.6 | 40.0 | 30.8 |
USA share of gross segment revenue (%) | 0.5 | 6.1 | 5.6 | 24.3 |
Europe share of gross segment revenue (%) | 24.7 | 44.4 | 54.3 | 45.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Revenue S&P basis (AUD Mn) | 5.32 | 4.49 | 7.70 | 9.43 |
Gross profit (AUD Mn) | 0.75 | 1.07 | 2.76 | 1.13 |
Operating income (AUD Mn) | -16.12 | -12.55 | -11.04 | -19.79 |
EBITDA derived (AUD Mn) | -14.36 | -10.90 | -10.88 | -19.45 |
Pre-tax income derived (AUD Mn) | -16.97 | -15.71 | -11.66 | -19.95 |
Net income (AUD Mn) | -16.97 | -15.71 | -11.89 | -19.89 |
EPS basic and diluted (AUD) | -0.09 | -0.07 | -0.01 | -0.02 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 |
Stock-based compensation (AUD Mn) | 3.32 | 2.02 | 4.16 | 6.03 |
Depreciation and amortisation (AUD Mn) | 1.76 | 1.65 | 0.16 | 0.34 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Gross margin (%) | 14.1 | 23.8 | 35.9 | 12.0 |
Operating margin (%) | -303.0 | -279.7 | -143.5 | -210.0 |
EBITDA margin (%) | -270.0 | -242.8 | -141.3 | -206.3 |
Net margin (%) | -319.0 | -350.0 | -154.5 | -210.9 |
Cash Flow
| Metric | TP2025 (6M to 31 Dec 2025) | H1 2026 (6M to 30 Jun 2026) |
|---|---|---|
Revenue (AUD Mn) | 5.27 | 4.87 |
Revenue change vs prior comparable period | Not comparable (12-month comparative) | -11.1% vs H1 2025 |
Net loss after tax (AUD Mn) | -17.85 | -19.35 |
Net loss change | — | +45.3% wider vs H1 2025 |
Total comprehensive loss attributable to owners (AUD Mn) | — | -20.23 |
Cash at period end (AUD Mn) | 35.77 | 14.26 |
Customer receipts (AUD Mn) | — | 4.85 (Appendix 4C YTD) |
Net operating cash flow (AUD Mn) | -21.1 (derived: S&P TTM to Jun-26 less 4C H1 2026) | -14.28 |
Net investing cash flow (AUD Mn) | — | -6.63 |
Balance Sheet and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | TP2025 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 14.82 | 6.35 | 8.08 | 35.10 | 70.55 |
Cash and short-term investments (AUD Mn) | 7.63 | 1.47 | 2.73 | 8.93 | 35.77 |
Short-term debt incl current leases (AUD Mn) | 0.37 | 1.43 | 0.73 | 0.85 | 4.85 |
Long-term debt incl leases (AUD Mn) | 1.05 | 0.70 | 0.39 | 11.34 | 11.08 |
Total debt incl leases (AUD Mn) | 1.42 | 2.13 | 1.11 | 12.19 | 15.92 |
Net debt (AUD Mn; negative = net cash) | -6.21 | 0.66 | -1.62 | 3.26 | -19.85 |
Shareholders equity (AUD Mn) | 7.41 | -0.71 | 1.03 | 14.82 | 47.81 |
Goodwill and intangibles (AUD Mn) | 0.55 | 0 | 0 | 0 | 0 |
Property plant and equipment (AUD Mn) | 3.42 | 0.54 | 0.56 | 20.10 | 29.30 |
Inventory (AUD Mn) | 2.11 | 2.73 | 3.46 | 4.17 | 3.44 |
Working capital (AUD Mn) | 6.11 | 1.02 | 2.44 | 7.58 | 31.08 |
Shares outstanding period end (M) | 202.53 | 238.99 | 1,011.00 | 1,326.00 | 1,599.00 |
Cash Flow (FY2022–TP2025)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | TP2025 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -9.68 | -10.72 | -6.23 | -14.72 | -21.06 |
Capital expenditure (AUD Mn) | -1.07 | -0.93 | -0.90 | -14.90 | -3.08 |
Free cash flow (AUD Mn) | -10.75 | -11.65 | -7.13 | -29.62 | -24.14 |
Equity issued gross (AUD Mn) | 12.42 | 5.10 | 10.25 | 30.11 | 50.00 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | TP2025 |
|---|---|---|---|---|---|
Current ratio (x) | 2.29 | 1.21 | 1.49 | 2.03 | 4.07 |
Total debt to equity (x) | 0.19 | -3.00 | 1.08 | 0.82 | 0.33 |
ROA net loss over ending assets (%) | -114.5 | -247.4 | -147.2 | -56.7 | -25.3 |
Asset turnover revenue over ending assets (x) | 0.36 | 0.71 | 0.95 | 0.27 | 0.07 |
Financial Analysis
| Ratio | Assessment |
|---|---|
ROE | n/m. Equity was negative or near zero in FY2023–FY2024, producing distorted values; FY2025 net loss of A$19.9M against average equity of about A$7.9M implies roughly -250% |
ROIC | n/m (negative NOPAT in all years) |
Net debt / EBITDA | n/m (negative EBITDA in all years) |
Interest coverage | n/m (negative EBIT); cash interest paid rose to A$0.89M in the trailing period to Dec 2025 (S&P) |
Cash conversion cycle | Not computed. Payables and receivables are small relative to inventory, and inventory of about A$3.4–4.2M against negative or small gross profit implies very slow turns; customer deposits (unearned revenue A$2.16M at Jun-25, A$0.68M at Dec-25) partially fund working capital |
Revenue by Region
| Region | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Australia (APAC) revenue (AUD Mn) | 4.38 | 3.01 | 3.85 | 4.96 |
USA (Americas) revenue (AUD Mn) | 0.03 | 0.37 | 0.54 | 3.92 |
Europe (EMEA) revenue (AUD Mn) | 1.45 | 2.70 | 5.20 | 7.27 |
Region Margins & Growth (%)
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Australia growth (%) | -31.3 | 27.9 | 28.8 |
USA growth (%) | 1,133.3 | 45.9 | 625.9 |
Europe growth (%) | 86.2 | 92.6 | 39.8 |
Share Price History
| Date | Price (AUD) | Context | Source |
|---|---|---|---|
Sep 2016 | 0.20 | IPO price | Stockhead |
Jun 2025 | 0.30 | Maybank block purchase (8M shares, A$2.4M) | TipRanks |
Jul 2025 | 0.25 (approx.) | A$50M raise / 200M shares | ASX; TipRanks |
10 Oct 2025 | 0.49 | Insider/institutional trade price (approx. peak) | Simply Wall St insider data |
12 Mar 2026 | 0.21 | Redomicile announcement | InvestSMART |
13 May 2026 | 0.24 | Scheme Implementation Deed | InvestSMART |
28 Aug 2026 | 0.170 | Pre-placement close | Placement release |
2 Sep 2026 | 0.140 | Post-placement (-20.6%) | Kalkine |
14 Sep 2026 | 0.128 | USAF contract day (+10.9%) | Motley Fool |
16 Oct 2026 | 0.120 | Latest close (+14.3%) | StockAnalysis |
Valuation Multiples
| Multiple | Titomic | Basis |
|---|---|---|
Market capitalisation (AUD Mn) | About 214 | About 1,786M shares × A$0.12 |
Enterprise value (AUD Mn) | About 205 | Market cap less about A$25M pro-forma cash (Jun-26 cash A$14.3M plus about A$15.6M net placement less Q3 burn; estimate) plus about A$16M debt and leases |
EV / Sales (TTM revenue A$9.94M, S&P to Jun 2026) | About 20.6x | Estimate |
P/E | n/m (loss-making) | — |
EV / EBITDA | n/m (negative EBITDA) | — |
P/B | About 4.5–5.0x | Estimated equity of about A$44M (Dec-25 equity A$47.8M, less H1 2026 loss, plus placement) |
Analyst Conclusions
Management guidance (latest)
-
Revenue growth expected for the remainder of 2026, driven by defence contracts, energy, maritime sustainment and machine sales (Appendix 4D, Aug 2026).
-
Growth in customer orders and receipts expected in H2 2026 (Q2 2026 4C).
-
Cash flow and EBITDA break-even during 2027 (Q2 2026 4C; placement; restructure).
-
About A$3.0M of annualised cost savings, with the restructure complete by end Oct 2026.
-
Redomicile implementation expected by 30 Nov 2026.
-
Long-range: US$750M revenue by 2030 (Aug 2025); 13 conversion programs with illustrative US$250–430M revenue potential over 2026–2030 (not a forecast).
Consensus growth expectations
Not publicly available in verifiable form. Ord Minnett's Hold rating and A$0.18 target (Sep 2026) imply limited conviction in near-term delivery.
Bull case
-
Inflection in defence adoption. In about six weeks (Sep–Oct 2026), Titomic announced a US$5.0M USAF depot system, a Navy FRC Southwest order, a Bechtel Plant Machinery submarine-base evaluation and a Royal Netherlands Army prototype. If depot adoption replicates across USAF and Navy sites, revenue could step up sharply in 2027.
-
Production conversion is real, not theoretical. The semiconductor LRIP converted to full-rate production, and a defence-prime EMD article was delivered and tested. Both are evidence that the qualification-to-production pathway works and supports recurring revenue.
-
Funding gap could close non-dilutively. An EXIM loan of about US$10M, plus potential OSC capital, alongside A$3.0M of savings and tapering capex (Huntsville build-out "substantially complete"), could bridge the company to 2027 break-even without further deep-discount equity.
Bear case
-
Revenue is shrinking while losses widen. H1 2026 revenue fell 11.1% to A$4.87M while the net loss rose 45.3% to A$19.35M. Unit economics (gross margin of 12% in FY2025 and negative on a trailing basis) remain far from break-even, and a peer (AML3D) shows what good economics look like in the same niche.
-
Serial dilution and execution slippage. Share count is up about 9-fold since FY2022. The September 2026 raise came at a 23.5% discount. Redomicile timetables have slipped twice, and Q2 receipts disappointed, all of which erodes credibility of the US$750M 2030 target.
-
Order sizes are small relative to burn. Most 2026 orders are A$0.2–1.2M against roughly A$8M of quarterly operating outflow. Even the US$5.0M USAF order represents less than one quarter of cash burn, so many more wins, or a single large program, are needed.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Late Oct 2026 | Q3 2026 Appendix 4C | Customer receipts recovering above about A$3M per quarter; operating outflow trending below A$7M |
| Q4 2026 | EXIM and OSC funding decisions | Loan quantum, terms, covenants |
| By 30 Nov 2026 | Scheme meeting, court approval and implementation | Vote outcome; CDI mechanics; US listing timeline |
| H2 2026 – H1 2027 | Prime program progression beyond EMD | LRIP order from the unnamed defence prime |
| Dec 2026 | USAF system delivery and acceptance; TKF™623 deliveries (energy company, Compass Systems) | Revenue recognition timing |
| Feb–Mar 2027 | CY2026 annual report (first full calendar year) | Gross margin recovery; restructure savings visible |
| 2,027 | Semiconductor full-rate revenue (about A$1.5M); break-even trajectory | Evidence of recurring revenue mix |
| Ongoing | Further equity issuance | Size and discount of any future raise |
Concluding analyst verdict
Titomic is a credible technology company that has not yet become a credible business. Over 2024–2026 it accomplished a great deal operationally. It relocated its centre of gravity to Huntsville, built an AS9100-certified plant, recruited a defence-heavy board, secured DNV qualification, and won marquee validations from the USAF, the US Navy depot system, Bechtel Plant Machinery, Lufthansa Technik and a semiconductor customer now in full-rate production. The September–October 2026 newsflow is the strongest commercial run in the company's history, and it supports the view that TKF™ has a defensible role in defence sustainment and niche production.
The financial record, however, remains the binding constraint. Revenue of about A$10M on a trailing basis sits against net losses of about A$37M over the last twelve months (TP2025 and H1 2026 combined). Gross margins have deteriorated, H1 2026 revenue declined, and the balance sheet required a discounted A$16.5M placement after funding fell to 1.7 quarters. The US$750M-by-2030 ambition is not a useful valuation anchor; the 2027 break-even target is the relevant test.
At about A$0.12 per share (EV about A$205M, about 20x trailing sales), the market is still paying a substantial premium for optionality. That premium is justified only if 2027 delivers three things: multi-million-dollar recurring production contracts, gross margins approaching the 35–60% range seen in FY2024 and at peers, and non-dilutive US funding.
Verdict: Speculative / Hold. Titomic offers high-beta exposure to Western defence-industrial reshoring with genuine technology validation. Risk-reward hinges on Q3–Q4 2026 cash receipts, EXIM/OSC outcomes and successful redomiciliation. Investors should size positions for the material probability of further dilution, and should weight hard evidence of conversion (receipts and margins) above announcements of orders and partnerships.
Principal sources: Titomic ASX announcements and releases (FY2025 Annual Report release 28 Aug 2025; TP2025 Annual Report 27 Feb 2026; Q2 2026 Quarterly Activities Report and Appendix 4C 31 Jul 2026; Appendix 4D H1 2026 31 Aug 2026; placement, contract, scheme, AGM and restructure releases Mar–Oct 2026); titomic.com news pages; S&P Global Market Intelligence data via StockAnalysis.com; Quartr event summaries; Simply Wall St; TipRanks; MarketScreener; Kalkine; Discovery Alert; SmallCaps; Mining.com.au; The Motley Fool Australia; Proactive Investors; Australian Manufacturing; Business Wire (2020–2021); AML3D Appendix 4E and results release (31 Aug 2026). Figures marked "derived" or "estimate" are analyst calculations from these sources.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / background | Total remuneration (latest disclosed) |
|---|---|---|---|---|
Jim Simpson | CEO and Managing Director (Director since 10 Jan 2025) | CEO since 2024; previously US President | Aerospace and defence executive; recruited to lead US expansion | A$861.6k total (about 61% salary, 39% bonus/equity), per Simply Wall St summary of the latest remuneration report; holds about 0.36% |
Dag W. R. Strømme | Executive Chair | Board since 1 Jul 2020; Chair since 2 Oct 2023; Executive Chair since 2024 | Former MD, Morgan Stanley (2001–2007); Chair of Axactor ASA (2017–2018); Co-Chair PAACS Invest AS; Chair Racom AS | A$227.7k (latest disclosed); held about 30.6M shares (1.9%) at Dec 2025 and exercised 52.5M options in Sep 2026 |
Geoff Hollis | CFO and Company Secretary | Since 2024 | CFO and Company Secretary, Lifestyle Communities (2011–2018); CFO, Victory Offices (2019–2020); Company Secretary, Imagion Biosystems (2024); Chartered Accountant | A$948.1k (latest disclosed) |
Dr Patti Dare | President, Titomic USA | — | US operations leader; media contact | — |
Chris Myers | President, Titomic Europe | Since early 2026 | Not publicly disclosed in reviewed sources | — |
Ferdy Touwen | Deputy President and Head of European Operations | Since early 2026 | Promoted internally | — |
Klaas Rozema | Senior Executive Advisor (planned sabbatical) | Founder of Dycomet; GM Titomic Europe from Nov 2021 | Founded Dycomet (2006) | Not separately verified |
“—” = not publicly disclosed.
Board of Directors
| Director | Role | Independence | Appointed | Notes |
|---|---|---|---|---|
Dag W. R. Strømme | Executive Chair | Non-independent (executive) | 1 Jul 2020 | Re-elected at the Sep 2026 AGM with 99.38% support |
Jim Simpson | CEO and Managing Director | Non-independent (executive) | 10 Jan 2025 | — |
Humphrey Nolan | Deputy Chair, Non-Executive Director | Independent | 1 Jul 2020 | Chair of Nolan Group and Tapex Group; re-elected Sep 2026 (99.44%); holds about 3.31% |
Mira Ricardel | Non-Executive Director | Independent | 2021 | Principal, Chertoff Group; former senior US government official; sold 1.7M shares at A$0.225 on 7 Apr 2026 |
Lt Gen (ret.) John Frewen AO DSC | Non-Executive Director | Independent | 1 Jul 2025 | Former senior Australian Army officer |
Lt Gen (ret.) Henry "Trey" Obering III | Non-Executive Director | Independent | 11 Mar 2026 | Former Director, US Missile Defense Agency; elected at the Sep 2026 AGM (99.63%); 5,000,000 options approved (98.74%) |
Jim Chilton | Non-Executive Director | Independent | 15 Sep 2026 | Boeing veteran; joined Titomic in an advisory capacity in Jan 2026; succeeds Dr Andreas Schwer |
Dr Andreas Schwer | Former Chair / NED | — | About 2020/21 to Sep 2026 | Retired Sep 2026 after nearly six years |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Jul 2025 | John Frewen appointed NED | Sovereign/defence capability |
6 Jan 2026 | European leadership reshuffle (Myers, Touwen, Rozema) | Succession and execution focus |
27 Jan 2026 | Boeing veteran Jim Chilton joins Titomic | Aerospace credibility |
11 Mar 2026 | Lt Gen Trey Obering appointed NED | Missile defence domain |
13 Feb 2026 | CEO Jim Simpson sold 472,000 shares (about A$101k) | Insider selling |
15 Sep 2026 | Chilton joins board; Schwer retires | Board refresh |
7 Sep 2026 | Exec Chair Strømme exercises 52.5M options | Increases insider ownership |
Major Shareholders
| Holder | Stake | Date / basis | Source |
|---|---|---|---|
Regal Partners Limited | About 8.5% | Ownership summary c. 2025; Regal traded large blocks around Jun–Jul 2025 | Simply Wall St |
Maybank Securities Pte Ltd (asset management arm) | 8.09% (up from 7.49%) | Substantial holder notice c. Jun 2025; further purchases Aug–Nov 2025 | TipRanks / Simply Wall St |
Morgan Stanley and subsidiaries | 7.65% | Substantial holder notice (2025) | TipRanks |
Macquarie Group | About 5.3% (holding changes reported 18–19 Dec 2025) | 2025 | Simply Wall St |
Humphrey Nolan (director) | About 3.31% | Latest disclosed | Simply Wall St |
Dag Strømme (Exec Chair) | 1.9% at Dec 2025, plus 52.5M shares from options in Sep 2026 | Director interest notices | MarketScreener |
Jim Simpson (CEO) | About 0.36% | Latest disclosed | Simply Wall St |
Competitive Landscape
Key Competitors
| Competitor | HQ / ownership | Segment overlap | Relative positioning vs Titomic |
|---|---|---|---|
SPEE3D | Australia; private | Cold spray AM systems; expeditionary/military deployments | Closest technology peer; strong defence field-deployment profile; financials not publicly disclosed |
Impact Innovations GmbH | Germany; private | High-pressure cold spray systems | Established European high-pressure OEM; financials not publicly disclosed |
VRC Metal Systems | USA; private | Portable high-pressure cold spray for US defence sustainment | Direct US defence depot competitor; financials not publicly disclosed |
CenterLine (Windsor) Ltd / SST | Canada; private | Low-pressure cold spray systems | Competes in low-pressure / MRO; financials not publicly disclosed |
Plasma Giken | Japan; private | High-pressure cold spray systems | Asian high-pressure OEM; financials not publicly disclosed |
Oerlikon (Metco) | Switzerland; listed (SIX: OERL) | Thermal spray and coatings services, including cold spray | — |
AML3D Limited | Australia; ASX: AL3 | Wire-arc additive manufacturing (ARCEMY®) for US Navy submarine/maritime industrial base | Most direct listed comparator for "Australian AM company scaling in the US Navy industrial base" |
Velo3D | USA; listed | Laser powder-bed fusion for space/defence | — |
Nikon SLM Solutions | Germany (Nikon-owned) | Laser powder-bed fusion systems | — |
Sciaky (Phillips Service Industries) | USA; private | Electron-beam AM (large titanium parts) | Large-part metal AM alternative; financials not publicly disclosed |
Conventional suppliers (forgings, castings, machining, welding repair) | Various | Incumbent repair and production routes | The main substitute Titomic displaces on lead time and capability |
Peer Comparison FY2025
| Metric | Titomic (TTT) | AML3D (AL3) |
|---|---|---|
Latest annual revenue (AUD Mn) | 9.43 | 12.47 |
Revenue period | FY to Jun 2025 (S&P basis) | FY to Jun 2026 (incl. lease income) |
Latest revenue growth (%) | 22.5 | 70.0 |
Gross margin (%) | 12.0 | 63.0 |
Net loss latest annual (AUD Mn) | -19.89 | -4.48 |
Net margin (%) | -210.9 | -35.9 |



